Vitamin E Blood Pressure Meta-analysis: What the Evidence Says

Quick Answer

Vitamin E Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• A risk-of-bias analysis indicated that all studies were of medium to high quality. [Aragón-Vela Jerónimo (2026); evidence level 1]
• When analyzed in isolation, neither vitamin C ( = .094) nor vitamin E ( = .101) reduced the insulin levels. [Aragón-Vela Jerónimo (2026); evidence level 1]
• Experimental data and clinical studies highlight the cardiometabolic changes associated with gonadal aging and reproductive hormones' withdrawal. [Karaflou Maria (2026); evidence level 3]
• Body composition changes with increased fat mass and abdominal fat distribution are associated with insulin resistance and subsequent diabetes in older ages. [Karaflou Maria (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For vitamin e blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Aragón-Vela Jerónimo (2026). Effects of Vitamin C and/or E Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: A Systematic Review and Subgroup Meta-analysis. DOI: 10.1093/nutrit/nuaf133. PMCID: PMC12793614. PMID: 41521729. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12793614/
• Karaflou Maria (2026). Antioxidants in Menopausal Transition and Male Late-Onset Hypogonadism for the Prevention of Diabetes. DOI: 10.3390/antiox15060659. PMCID: PMC13296154. PMID: 42351965. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13296154/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.